Belting Mattias, Wittrup Anders
Department of Clinical Sciences, Section of Oncology, Lund University, Sweden.
Methods Mol Biol. 2009;480:1-10. doi: 10.1007/978-1-59745-429-2_1.
Macromolecular drugs hold great promise as novel therapeutics of several major disorders, such as cancer and cardiovascular disease. However, their use is limited by lack of efficient, safe, and specific delivery strategies. Successful development of such strategies requires interdisciplinary collaborations involving researchers with expertise on, e.g., polymer chemistry, cell biology, nanotechnology, systems biology, advanced imaging methods, and clinical medicine. This not only poses obvious challenges to the scientific community but also provides opportunities for the unexpected at the interface between different disciplines. This introductory chapter summarizes and gives references to studies on macromolecular delivery that should be of interest to a broad scientific audience involved in macromolecular drug synthesis as well as in vitro and in vivo drug delivery studies.
大分子药物作为治疗癌症和心血管疾病等几种主要疾病的新型疗法具有巨大潜力。然而,它们的应用受到缺乏高效、安全和特异性递送策略的限制。成功开发此类策略需要跨学科合作,涉及聚合物化学、细胞生物学、纳米技术、系统生物学、先进成像方法和临床医学等领域的专家。这不仅给科学界带来了明显挑战,也为不同学科之间的交叉领域带来了意外机遇。本章引言总结并引用了大分子递送研究,这些研究应该会引起参与大分子药物合成以及体外和体内药物递送研究的广大科学受众的兴趣。